Please login or register first to view this content.
Cardiovascular Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Non-Vitamin K Oral Anticoagulants May Be Best for Early-Stage CKD
Alirocumab Cuts CV Absolute Risk the Most for Those With Diabetes
FDA Approves Sprinkle Formulation of Rosuvastatin
Contrast Agent Gadavist Approved for Use in Cardiac MRI
FDA Approves Amlodipine Oral Suspension Katerzia
WHO Updates List of Essential Medicines
Dabigatran Safe, Effective for Managing VTE in Pediatric Trials
Most Supplements Offer Little Protection Against Heart Disease
Rivaroxaban May Be Safe, Effective for Pediatric VTE Treatment, Says Study
Recurrent DVT in a Morbidly Obese Patient Taking Rivaroxaban
Three Interventions Could Cut Cardiovascular Deaths
Empagliflozin Fast-Tracked for Chronic Heart Failure Treatment
Smoking Confers Greatest Risk for Major Heart Attack for Women
Lipid-Lowering Effects of Turmeric, Curcuminoids Examined
Intramyocardial Cell Therapy Revascor Gets Orphan Drug Designation
NDA for Investigational Antiarrhythmic Agent Brinavess Resubmitted to FDA
No Change Seen in Processed Meat Consumption by US Adults
RNAi Therapeutic Gets Orphan Drug Status for Familial Chylomicronemia Syndrome
